Page last updated: 2024-09-05

sorafenib and CCT251545

sorafenib has been researched along with CCT251545 in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(CCT251545)
Trials
(CCT251545)
Recent Studies (post-2010) (CCT251545)
6,5207305,251807

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)CCT251545 (IC50)
Cyclin-CHomo sapiens (human)0.006
Cyclin-dependent kinase 8Homo sapiens (human)0.0169
Glycogen synthase kinase-3 alphaHomo sapiens (human)0.462
Glycogen synthase kinase-3 betaHomo sapiens (human)0.69
Protein Wnt-3aHomo sapiens (human)0.007
Cyclin-dependent kinase 19Homo sapiens (human)0.0055

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adeniji-Popoola, O; Blagg, J; Blaukat, A; Box, G; Clarke, PA; Court, W; Czodrowski, P; Dale, T; de Haven Brandon, A; Eccles, SA; Esdar, C; Ewan, K; Fraser, E; Gowan, S; Mallinger, A; Musil, D; Ortiz-Ruiz, MJ; Poeschke, O; Raynaud, F; Rohdich, F; Samant, RS; Schiemann, K; Schneider, K; Schneider, R; Schwarz, D; Stubbs, M; TePoele, R; Valenti, M; Waalboer, D; Wienke, D; Workman, P1

Other Studies

1 other study(ies) available for sorafenib and CCT251545

ArticleYear
A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease.
    Nature chemical biology, 2015, Volume: 11, Issue:12

    Topics: Cell Line, Tumor; Colonic Neoplasms; Cyclin-Dependent Kinase 8; Cyclin-Dependent Kinases; Humans; Models, Molecular; Molecular Probes; Molecular Structure; Protein Kinase Inhibitors; Pyridines; Spiro Compounds

2015